SCHEMBL3944846

SCHEMBL3944846

Nc1nc(Cl)cc(-c2ccc(Cl)cc2Cl)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 10/20 1.00
HSP90AA1 P07900 9/20 1.00
LMNA P02545 2/20 0.53
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.50
POLB P06746 1/20 0.50
RAB9A P51151 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PTPN1 P18031 1/20 0.49
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
BACE1 P56817 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4281889 0.86 HSP90AB1 (0.75) HSP90AB1HSP90AA1KDM4EPTPN1AGPAT2
SCHEMBL7380404 0.86 HSP90AA1 (0.75) HSP90AB1HSP90AA1LMNAKDM4EMAPT
SCHEMBL29287110 0.83 HSP90AB1 (0.71) HSP90AB1HSP90AA1KDM4EMAPTMEN1
SCHEMBL3944332 0.83 HSP90AA1 (0.71) HSP90AB1HSP90AA1KDM4EAGPAT2CDC7
SCHEMBL15757653 0.80 HSP90AA1 (0.67) HSP90AB1HSP90AA1KDM4EAGPAT2HTR2B
SCHEMBL3950560 0.80 HSP90AA1 (1.00) HSP90AB1HSP90AA1KDM4EPTPN1KMT2A
SCHEMBL4291570 0.79 HSP90AA1 (0.66) HSP90AB1HSP90AA1LMNAKDM4EMAPT
SCHEMBL4282884 0.79 AGPAT2 (0.67) HSP90AB1HSP90AA1KDM4EAGPAT2
SCHEMBL3945098 0.79 HSP90AA1 (1.00) HSP90AB1HSP90AA1KDM4EMAPTNPC1
SCHEMBL15757500 0.79 HSP90AA1 (0.66) HSP90AB1HSP90AA1LMNAPTPN1AGPAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed
EP-2049497-A2 PYRIMIDINE DERIVATIVES AS HSP90 INHIBITORS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
WO-2006123165-A2 PYRIMIDINE DERIVATIVES AS HSP90 INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors HSP90AB1, HSP90AB2P, HSP90B1 HSP90AB1 1/4885HSP90AA1 4/4885LMNA 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.